Novo Nordisk A/S

Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15.7% of their […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy. The cash-pay offering is available to millions of patients […]
Read More
Amgen starts two critical late-stage trials for weight loss drug MariTide
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market. “We’re delighted to share […]
Read More
Healthy Returns: AbbVie is the newest potential weight loss drug market player
A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor. AbbVie […]
Read More
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes […]
Read More
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes […]
Read More